Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome. [electronic resource]

By: Contributor(s): Producer: 20200716Description: e151-e155 p. digitalISSN:
  • 1365-2141
Subject(s): Online resources: In: British journal of haematology vol. 186
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.